InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (32 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
32
T+90 hit rate
39%
T+90 mean return
-3.5%
Across 41 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Kim Paul, Chief Financial Officer. Insider active across 1 company, notably Fulgent Genetics, Inc.. Aggregated, 77 filings have been published. Breakdown: 1 buy · 32 sells. Total volume traded: €6m. History available since 18 May 2021. The latest transaction was filed on 26 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations77 total
1,168 shares@ US$17.670.0034% mcap0.6% of flowCommon StockSEC:0001253820-26-000003:0
1,168 shares@ US$24.7650.0% of flowCommon StockSEC:0001253820-26-000001
1,168 shares@ US$24.760.0055% mcap50.0% of flowCommon StockSEC:0001253820-26-000001:0
2,743 shares@ US$18.881.5% of flowCommon StockSEC:0000950170-25-060280:0
100,000 shares@ US$15.964749.4% of flowCommon StockSEC:0000950170-25-033994:0
Ideal exit: 30 Nov 2025 (T+270)
1,556 shares@ US$15.450.8% of flowCommon StockSEC:0000950170-25-032775:0
3,384 shares0Common StockSEC:0000950170-25-029436:0
733 shares@ US$16.460.4% of flowCommon StockSEC:0000950170-25-026883:0
3,000 shares@ US$17.211.6% of flowCommon StockSEC:0000950170-25-009842:0
1,553 shares@ US$18.300.9% of flowCommon StockSEC:0000950170-24-133315:0
669 shares@ US$17.870.4% of flowCommon StockSEC:0000950170-24-131592:0
2,738 shares@ US$19.421.6% of flowCommon StockSEC:0000950170-24-118287:0
1,674 shares@ US$21.9611.1% of flowCommon StockSEC:0000950170-24-104024:0
733 shares@ US$22.8330.5% of flowCommon StockSEC:0000950170-24-101986:0
1,412 shares@ US$25.061.1% of flowCommon StockSEC:0000950170-24-091816:0
2,738 shares@ US$23.662.0% of flowCommon StockSEC:0000950170-24-087891:0
1,129 shares@ US$20.650.7% of flowCommon StockSEC:0000950170-24-068793:0
669 shares@ US$21.140.4% of flowCommon StockSEC:0000950170-24-065239:0
1,412 shares@ US$21.500.9% of flowCommon StockSEC:0000950170-24-054557:0
2,738 shares@ US$20.101.7% of flowCommon StockSEC:0000950170-24-050512:0
1,129 shares@ US$23.240.8% of flowCommon StockSEC:0000950170-24-026007:0
3,927 shares0Common StockSEC:0000950170-24-022465:0
2,670 shares@ US$24.061.9% of flowCommon StockSEC:0000950170-24-021522:0
982 shares@ US$24.650.7% of flowCommon StockSEC:0000950170-24-011858:0
1,988 shares@ US$25.601.5% of flowCommon StockSEC:0000950170-24-008855:0
25 of 77 declarations
About Kim Paul
Kim Paul is the Chief Financial Officer of Fulgent Genetics, Inc.
